Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor EfficacyMelissa G Lechner, Mandy I Cheng, Anushi Y Patel, et al.Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer geneCristina Montero-Conde, Luis J Leandro-Garcia, Xu Chen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A Thompson, Bryan J Schneider, Julie Brahmer, et al.JCI Insight|July 8, 2025
Polyfunctional T follicular helper cells drive checkpoint-inhibitor diabetes and are targeted by JAK inhibitor therapyNicole L Huang, Jessica G Ortega, Kyleigh Kimbrell, et al.Science Translational Medicine|May 17, 2023
Clonally expanded, thyrotoxic effector CD8+ T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditisMelissa G Lechner, Zikang Zhou, Aline T Hoang, et al.Journal of the Endocrine Society|March 2, 2023
Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced HypophysitisZoe Quandt, Stephanie Kim, Javier Villanueva-Meyer, et al.Proceedings of the National Academy of Sciences of the United States of America|January 21, 2022
Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunityYan Wang, Lily Guo, Xihui Yin, et al.Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.Pancreas|May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and ParagangliomaLauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.Pageof 11